Back to search

The assessment of antagonist potency under conditions of transient response kinetics

Data up to Jan 2025

Published1999
Citations65
References29

Total Citations Per Year

Abstract

References (29)

A new generation of Ca2+ indicators with greatly improved fluorescence properties.

1985 • 21,873 citations

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1973 • 12,522 citations

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

1959 • 3,948 citations

Muscarinic Receptors—Characterization, coupling and function

1993 • 1,264 citations

Operational models of pharmacological agonism

1983 • 1,062 citations

Pharmacologic Analysis of Drug Receptor Interaction

1988 • 936 citations

Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors

1998 • 880 citations

The margin of safety of neuromuscular transmission

1967 • 409 citations

Pharmacologic analysis of drug-receptor interaction

1995 • 255 citations

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype

1993 • 254 citations

pAx AND COMPETITIVE DRUG ANTAGONISM

1949 • 247 citations

Assessing the distribution of parameters in models of ligand–receptor interaction: to log or not to log

1998 • 174 citations

Muscarinic receptor differentiation

1988 • 158 citations

Analysis of competitive agonist-antagonist interactions by nonlinear regression

1995 • 143 citations

Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.

1980 • 121 citations

Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model

1994 • 65 citations

Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action

1992 • 65 citations

On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.

1998 • 61 citations

Qualitative and quantitative assessment of relative agonist efficacy

1999 • 55 citations

Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.

1989 • 35 citations

Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor

1995 • 25 citations

Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists

1990 • 22 citations

Antihistaminic and antimuscarinic effects of amitriptyline on guinea pig ileal electrolyte transport and muscle contractility in vitro.

1988 • 21 citations

M1 Muscarinic Receptors Stimulate Rapid and Prolonged Phases of Neuronal Nitric Oxide Synthase Activity: Involvement of Different Calcium Pools

1998 • 20 citations

Different apparent modes of inhibition of α2A-adrenoceptor by α2-adrenoceptor antagonists

1997 • 19 citations

Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.

1988 • 18 citations

N, N-Diethy1-2-(1-pyridyl)ethylamine, a partial agonist for the histamine receptor in guinea pig ileum

1980 • 17 citations

Pseudo-Noncompetitive Antagonism of M1, M3, and M5Muscarinic Receptor-Mediated Ca2+Mobilization by Muscarinic Antagonists

1998 • 15 citations

Promiscuous or heterogeneous muscarinic receptors in rat atria? II. Antagonism of responses to carbachol by pirenzepine

1990 • 6 citations

Cited By (0)

Loading...
The assessment of antagonist potency under conditions of transient response kinetics (1999) – European Journal of Pharmacology | Metascience Observatory Explorer